CRV431
Showing 1 - 4 of 4
NASH With Fibrosis Trial ([14C]-rencofilstat 225mg)
Not yet recruiting
- NASH With Fibrosis
- [14C]-rencofilstat 225mg
- (no location specified)
Feb 21, 2023
Hepatitis B, Infectious Disease, Liver Diseases Trial in Tempe, Lincoln, San Antonio (CRV431, Placebo, TDF)
Completed
- Hepatitis B
- +2 more
- CRV431
- +2 more
-
Tempe, Arizona
- +2 more
Nov 30, 2021
Nonalcoholic Steatohepatitis (NASH), Fibrosis, Liver, NAFLD Trial (Rencofilstat, Placebo)
Recruiting
- Nonalcoholic Steatohepatitis (NASH)
- +2 more
- Rencofilstat
- Placebo
-
Huntsville, Alabama
- +40 more
Dec 7, 2022
NASH With Fibrosis Trial (rencofilstat, 75 mg, rencofilstat, 150mg, rencofilstat, 225 mg)
Not yet recruiting
- NASH With Fibrosis
- rencofilstat, 75 mg
- +2 more
- (no location specified)
Jul 13, 2022